Patent Assignment
Reel/Frame 018296/0904
License
Recorded: 2006-09-26
Pages: 20
Assignor
CHANG, LUNG-JI, DR.
Executed: 1998-09-21
Assignee
ACUVECTOR GROUP INC.
11219 - 25 AVENUE, EDMONTON, ALBERTA, T6J 4X5, CANADA
Covered Properties
(8)
Retroviral Expression Vectors Containing Momlv/Cmv-1E/Hiv-Tar Chimeric Long Terminal Repeats
Patent:
5,693,508 →
Application:
08/336,132 →
Recombinant Hepatitis Virus Vectors
Patent:
5,981,274 →
Application:
08/715,808 →
Method of Using Mouse Model for Evaluation of Hiv Vaccines
Patent:
6,248,721 →
Application:
08/848,760 →
Lentiviral Vectors
Patent:
6,207,455 →
Application:
08/935,312 →
Lentiviral Vectors
Patent:
6,531,123 →
Application:
09/318,138 →
Combination Immunogene Therapy
Long term expression of lentiviral vectors
Application:
10/455,080 →
Publication:
US 2004/0002158
Modified dendritic cells
Application:
11/122,456 →
Publication:
US 2006/0013803
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 11, 2002
From: CHANG, LUNG-JI
To: AMDL, INC.
Reel/Frame 012800/0655 →
Statement of Claim Filed in the Court of Queen's Bench of Alberta Judicial District of Edmonton
Sep 26, 2006
From: CHANG, LUNG-JI; AMDL INC.
To: ACUVECTOR GROUP INC.
Reel/Frame 018296/0942 →
Assignment of Assignor's Interest
Dec 27, 2007
From: CHANG, LUNG-JI
To: INNOVA SCIENCE PTE. LTD.
Reel/Frame 020288/0649 →
Assignment of Assignor's Interest
Dec 27, 2007
From: CHANG, LUNG-JI
To: INNOVA SCIENCE PTE. LTD.
Reel/Frame 020288/0652 →
Change of Name
Feb 28, 2012
From: AMDL, INC.
To: RADIENT PHARMACEUTICALS CORPORATION
Reel/Frame 027779/0589 →